These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4545315)

  • 1. [Determination of kallikreinogen and kallikrein inhibitors in blood plasma].
    Veremiienko KM; Volokhons'kaia LI; Kizim OI; Meged' NF
    Ukr Biokhim Zh; 1974; 46(2):246-51. PubMed ID: 4545315
    [No Abstract]   [Full Text] [Related]  

  • 2. Prekallikein and kallikrein inhibitor in liver cirrhosis and hepatitis.
    Faciullacci M; Galli P; Monetti MG; Pela I; Del Bianco PL
    Adv Exp Med Biol; 1976; 70(00):201-8. PubMed ID: 1084679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observations on the plasma kallikrein system during myocardial ischemia.
    Pitt B; Mason J; Conti CR; Colman RW
    Trans Assoc Am Physicians; 1969; 82():98-108. PubMed ID: 5310289
    [No Abstract]   [Full Text] [Related]  

  • 4. Observations on the plasma kallikreinogen (prekallikrein)-kallikrein enzyme system.
    Sherry S; Colman RW
    Trans Assoc Am Physicians; 1968; 81():40-8. PubMed ID: 5305252
    [No Abstract]   [Full Text] [Related]  

  • 5. [Enzyme dynamics of the quinine system in the acute phase of the myocardial infarct: levels of kallikreinogen and of the kallikrein inhibitor].
    Del Bianco PL; Sicuteri F; Fumagalli C
    Boll Soc Ital Cardiol; 1972; 17(9):739-46. PubMed ID: 4549727
    [No Abstract]   [Full Text] [Related]  

  • 6. [Measurement of plasma kallikrein inhibitor using purified human plasma kallikrein].
    Haneda Y; Denpo Y; Chiba Y; Yoshida Y
    Rinsho Ketsueki; 1983 Mar; 24(3):225-31. PubMed ID: 6193294
    [No Abstract]   [Full Text] [Related]  

  • 7. [Method for determining kallikrein of tissue origin in blood plasma and its clinical significance].
    Surovkina MS; Semenova LV; Semenov VI; Lapshina IM; Volkova TV
    Biull Eksp Biol Med; 1985 Aug; 100(8):249-52. PubMed ID: 3849314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histamine and kallikrein system in man.
    Pedata F; Del Bianco PL; Curradi C; Anselmi B; Sicuteri F
    Adv Exp Med Biol; 1976; 70(00):229-34. PubMed ID: 1084681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of aprotinin and gabexate mesilate on human plasma kallikrein.
    Nakahara M
    Arzneimittelforschung; 1983; 33(7):969-71. PubMed ID: 6194800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness of commercial polyvalent proteinase inhibitors. Comparative analysis of their effect on kallikreins from different sources and trypsin].
    Iarovaia GA; Dotsenko VL; Agapova EI; Stepanian EP
    Vopr Med Khim; 1980; 26(6):832-7. PubMed ID: 6161484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of three forms of plasma kallikrein and its adsorption on kaolin using the colorimetric method].
    Surovikina MS; Stamm MV; Surovikin VV
    Biull Eksp Biol Med; 1997 Jan; 123(1):111-4. PubMed ID: 9213445
    [No Abstract]   [Full Text] [Related]  

  • 12. [The state of various components of the kallikrein-kinin system of the blood plasma in children with rheumatoid arthritis during sanatorium and health resort treatment].
    Kudria VI
    Vopr Kurortol Fizioter Lech Fiz Kult; 1984; (2):31-3. PubMed ID: 6203220
    [No Abstract]   [Full Text] [Related]  

  • 13. The kinetics of the release of bradykinin by kallikrein in normal human plasma.
    Girey GJ; Talamo RC; Colman RW
    J Lab Clin Med; 1972 Oct; 80(4):496-505. PubMed ID: 4627469
    [No Abstract]   [Full Text] [Related]  

  • 14. [Indicators of the kallikrein-kinin system of the blood in uterine myoma].
    Tserikidze AG; Diugeev AN; Ibragimov AI
    Sov Med; 1986; (7):33-7. PubMed ID: 2429373
    [No Abstract]   [Full Text] [Related]  

  • 15. [Kallikrein activity and the inhibitory capacity of the blood plasma in experimental hemorrhagic shock in dogs].
    Kühne H; Lehmann B; Scheuch DW
    Khirurgiia (Sofiia); 1979; 32(4):273-8. PubMed ID: 316041
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of a novel kallikrein inhibitor on hemostatic activation in vitro.
    Tanaka KA; Szlam F; Katori N; Vega JD; Levy JH
    Thromb Res; 2004; 113(5):333-9. PubMed ID: 15183046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excess antibody immunoassay for rat glandular kallikrein. Measurement of kallikrein complexed with inhibitors and in plasma.
    Johansen L; Nustad K; Berg T; Pierce JV
    J Immunol Methods; 1984 Apr; 69(2):253-66. PubMed ID: 6201559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The kallikreinogen-kallikrein enzyme system of human plasma. Assay of components and observations in disease states.
    Colman RW; Mason JW; Sherry S
    Ann Intern Med; 1969 Oct; 71(4):763-73. PubMed ID: 5360288
    [No Abstract]   [Full Text] [Related]  

  • 19. [Method of determining contact prekallikrein and inhibitors of kallikrein in the blood plasma of man].
    Veremeenko KN; Volokhonskaia LI; Kizim AI; Meged' NF
    Lab Delo; 1975; (1):9-12. PubMed ID: 45984
    [No Abstract]   [Full Text] [Related]  

  • 20. [A simplified method for determining kallikreinogen and kallikrein in human blood (plasma) under normal conditions and in several pathologic states].
    Paskhina TS; Krinskaia AV
    Vopr Med Khim; 1974; 20(6):660-3. PubMed ID: 4450536
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.